Ganfule capsule alleviates bile duct ligation-induced liver fibrosis in mice by inhibiting glutamine metabolism

Background: Liver fibrosis is a pathological outcome of a variety of liver diseases, and it can also progress into liver cirrhosis and liver cancer. Specific liver antifibrotic drugs have not been clinically approved yet. Studies have demonstrated the protective effects of Ganfule capsule (GFL) on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Chang, Gao, Jianlong, Tu, Jiyuan, Wang, Yan, Xiao, Yangxin, Wu, Yuan, Liu, Yanju, Zhou, Zhongshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585157/
https://www.ncbi.nlm.nih.gov/pubmed/36278176
http://dx.doi.org/10.3389/fphar.2022.930785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585157/
https://www.ncbi.nlm.nih.gov/pubmed/36278176
http://dx.doi.org/10.3389/fphar.2022.930785

Ejemplares similares